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CHAPTER I 
INTRODUCTION 
If vitamin A could tell its secrets, what an interesting story 
we would probably hear. The existence of a "fat soluble A" factor 
has been known for 67 years (1, 2) but little of the biological role 
of vitamin A is understood. Vitamin A has been shown to be involved 
in several biological functions, including vision (3), growth and 
differentiation (4), reproduction (5), and maintenance of epithelial 
tissues (6). More recently, vitamin A compounds have been employed 
in the treatment and chemoprevention of cancer (7-10), acne (11), and 
linked to glycoprotein synthesis (12-14). A series of publications 
by Olson (15-17), Dowling and Wald (4, 18), and Thomas Moore's book, 
Vitamin A (3), provide an excellent background on vitamin A. The term 
"vitamins A" as used here will include retinol and compounds similar 
to retinol in structure and function. Natural and synthetic analogs 
of vitamin A will be collectively referred to as "retinoids" (7). 
The role of retinal in the visual process is well known (3), and 
is the only well characterized function of vitamin A. The search for 
an "active form" of vitamin A has been unsuccessful. This is probably 
due to the fact that vitamin A, with its many functions in the body, 
has several active forms. Retinoic acid, touted by some as an "active 
form" of vitamin A, replaced retinol in the support of growth in rat 
(4), chick (19), and pig (20), but blindness ensued if it was the sole 
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retinoid supplied (4). Retinoic acid had a sparing effect on liver 
vitamin A stores in chicks (19) and pigs (20). It did not, however, 
support pregnancy in female rats or spermatogenesis in male rats (21, 
22). Chicks fed methyl retinoate produced normal spermatozoa and 
eggs, but did not produce normal embryos (23). Isolation of separate 
specific cellular binding proteins for retinol and retinoic acid in 
human uterus suggested that both forms might be necessary for normal 
development of those cells (24). 
Vitamin A Proteins 
The major stores of vitamin A in the body are as retinyl esters 
in the liver. Retinol is transported in the blood plasma by a 
specific 21,000 dalton retinol-binding protein (RBP) (25-27) asso-
ciated with thyroxine-binding prealbumin. The complex apparently 
protects the conjugated unsaturated molecule from oxidation en route 
to target tissues (26). Retinoic acid is carried in the blood serum 
by serum albumin (28). The discovery of a cellular retinoic acid-
binding protein (CRABP) in rat testes by Ong and Chytil (29) and in 
chick embryo metatarsel skin by Sani et al. (30) was further evidence· 
of a cellular role for retinoic acid. Retinol did not compete with 
retinoic acid for binding, but instead bound tightly to a specific 
cellular retinol-binding protein (CRBP) (31) different from that 
found in serum (32-36). Both CRBP and CRABP were isolated from 
tissues of fetal rats (37). The CRBP was present in most tissues 
of the adult, but CRABP was absent in lung, liver, intestine, and 
kidney. The amounts of CRABP and CRBP in testes from retinol 
deficient rats were unchanged relative to those from pair fed control 
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rats (38). Ong et al. demonstrated that extracts of human carcinomas 
from lung and breast contained CRABP and that it was absent in normal 
lung or breast tissue from the same patients (38). Changes in the 
levels of the binding proteins at different stages of development 
suggest separate changing requirements for retinol and retinoic acid 
in organ maturation and development (37). 
Vitamin A appears to be an agent in the control of mitogenic 
activity and cell differentiation (17, 39-42). Christophers et al. 
working with guinea pig epidermal cells grown in vitro found that 
treatment of cells with retinoic acid significantly increased cellular 
attachment in the first hours after seeding followed by a ten-fold 
increase in DNA synthesis (43, 44). Boren et al. showed that in 
hamster trachea epithelium, the ratios of basal cells to mucus cells 
to ciliated cells were altered by vitamin A deficiency and excess 
(45) vitamin A deficiency caused an increase in basal cells and a 
decrease in ciliated cells. Vitamin A excess effected an increase 
in ciliated cells and a decrease in mucus cells (45). 
Vitamin A and Carcinogenesis 
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Recent studies have indicated that vitamin A and synthetic vitamin 
A analogs (retinoids) might be potent intermediates in the prevention 
of chemically induced carcinogenesis (7, 46). This is consistent with 
the role of vitamin A in enhancing cell differentiation since carcino-
genesis involves cell de-differentiation. The rationale for employing 
synthetic analogs in the treatment of carcinogenesis is underlined by 
the toxicity of known vitamin A compounds in the body (6). Bollag 
reported that retinoic acid had a prophylactic or therapeutic effect on 
the development of chemically induced papillomas and carcinomas of 
mice skin while a synthetic aromatic derivative had a therapeutic 
ratio (anti-carcinogenic activity/toxicity) ten times greater (47-51). 
The synthetic retinoids were bound by both CRABP, which is the 
cellular binding site for retinoic acid and serum albumin which is 
the transport vehicle in the blood (52, 53). Binding of the retinoids 
required the carboxyl on the side chain, but was not prevented by 
modifications on the ring (54). No correlation was found linking 
binding of derivatives with serum albumin to ability to inhibit 
tumors. The ability of analogs td bind CRABP did correlate with 
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tumor inhibiting activity in mouse skin, hamster trachea, human breast 
tumor, and rat testes (55) as defined by Sporn et al. (56). This 
suggested that retinoid activity at the cellular level was mediated by 
CRABP and supported the hypothesis that retinoic acid or a derivative 
thereof was active in stimulating cell differentiation in those tissues. 
Biological Role of Vitamin A 
At least one biological role of vitamin A on a cellular level has 
been studied. Based on extensive studies on pho-sphorylated derivatives 
of retinol and retinoic acid, it was proposed that phosphorylation of 
vitamin A and linkage of the phosphorylated derivative to mannose was 
necessary for incorporation of mannose into manno-glycoproteins (14, 
57-60). It has been reported vitamin A acts similarly as a carrier 
for galactose (61). Both retinol and retinoic acid were metabolized 
to forms that bound mannose but appeared to function in different ways. 
Synthetic retinyl phosphate accepted mannose in vivo, but synthetic 
retinoyl phosphate did not (58). Synthetic retinylphosphate co-chro-
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matographed with the compound formed in vivo from retinol in rat liver 
membranes. It was postulated that retinoic acid formed a similar 
hydroxylated derivative either by decarboxylation or reduction of the 
carboxyl group (60). The reduction of retinoic acid has never been 
demonstrated in vivo. 
A problem in vitamin A studies has been to define what constitutes 
a vitamin A deficient state in an intact laboratory animal. Nelson 
et al. developed a method for quantitation of retinoic acid and retinol 
in blood plasma (62) and showed that in pigs, cerebrospinal fluid 
pressure was an adequate and sensitive criterion for assessing vitamin 
A status in an animal (20). In pigs with a vitamin A deficiency, an 
increase in cerebrospinal fluid pressure was the first change to occur 
with decreasing blood plasma vitamin A levels •. Retinol and retinoic 
acid were equally effective in reducing cerebrospinal fluid pressure 
(20). 
Metabolism of Retinoic Acid 
Retinoic acid is a normal intermediate of the metabolism of 
retinol, retinal, and retinyl esters. Dunagin et al. injected rats 
intraportally with all-trans-[6,7-14c2]retinal and in 6 hours detected 
small amounts of retinoic acid in liver, intestine, and bile (63). 
The bile fraction contained up to 6% of the injected dose of retinal 
as some form of retinoic acid. Other studies have demonstrated a rapid 
conversion of retinal to retinoic acid (64). In vitro incubations of 
S-carotene with intestinal mucosa liberated small amounts of retinoic 
acid (65). Addition of NAD or NADH to the system stimulated retinoic 
acid production ten-fold. Ito et al. (66) dosed rats intrajugularly 
with all-trans-[11;.14c]retinyl acetate and recovered retinoic acid 
and a polar metabolite from all tissues examined. Retinoic acid was 
isolated from liver, intestine, testes, and bile 12 hours after 
intrajugular administration of all-trans-[15-14cJretinol (67). 
Retinoic acid itself is not a dead end of vitamin A metabolism. 
A significant finding in the study of the metabolism of retinoic acid 
was the discovery that 40% of injected retinoic acid was excreted in 
the bile of cannulated rats within 4 hours as water soluble material 
(68). Previously, investigators had been unable to explain the 
rapid disappearance of administered retinoic acid in laboratory 
animals. Characterization of 3 major fractions of metabolites in the 
bile demonstrated the presence of free retinoic acid, alkali labile 
esters of retinoic acid, retinoyl 13-glucuronide, and an unidentified 
polar metabolite. An enzyme was found which catalyzed formation of 
retinyl and retinoyl 8-glucuronide from retinol, retinoic acid, and 
UDP glucuronic acid (69, 70). The retinoyl 13-glucuronide was found 
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to have a biopotency 30-100% as great as all-trans-retinoic acid and 
to participate in enterohepatic circulation (71, 72). Ito et al. (73) 
quantitated the per cent dose of radioactivity in body tissues 1-48 
hours after intravenous dosage of 13 micrograms of all-trans-[6,7-14c2J 
retinoic acid. Bone, muscle, liver, and small intestine accounted for 
79.0% of the recovered dose in the first hour. The amounts of radio-
activity in these tissues decreased over the 48 hour period. After 
48 hours, 94.3% of the recovered dose was in the large intestine, 
feces, and urine. Sundaresan et al. reported the presence of at 
least 6 urinary metabolites from rats, the major one lacking Carbon 
1114 and Carbon 1115 of retinoic acid (74). 
Lehman (28) separated the metabolites of retinoic acid in chick 
bile into two fractions which he characterized as retinoyl S-glucuro-
nide and a polypeptide conjugate of retinoic acid of molecular weight 
> 1800 daltons. Dunagin et al. (63), using extractions and gas 
chromatography, divided the metabolites of retinoic acid in rat bile 
into 3 fractions one of which contained retinoyl 8-glucuronide. 
Roberts et al. (75-77) have reported evidence from a hamster liver 
microsome system and from hamster intestine that the major pathway of 
retinoic acid involves hydroxylation at position 4 in the ring, con-
version to a 4-keto group, and subsequent conversion to more polar 
metabolites. 
Decarboxylation of Retinoic Acid 
The decarboxylation of retinoic acid in vitro is a well studied 
phenomenon. Roberts et al. (78) and Lin (79) isolated a microsomal 
fraction capable of decarboxylating retinoic acid. Similarly, 
decarboxylation has been demonstrated with tissue slices from kidney 
(78) and liver (80). Tissue slices from animals dosed with N,N'-
diphenyl-p-phenylenediamine (DPPD), an antioxidant, showed decreased 
decarboxylation of retinoic acid in vitro (81). Rockley et al. (82, 
83) identified a C-19 aldehyde as the major decarboxylation product 
7 
in a model system composed of all-trans-retinoic acid, H2o2 , and 
horseradish peroxidase. The isolation and characterization of decar-
boxylated retinoids produced in vivo has been poorly accomplished. 
Sundaresan et al. (84) reported up to 14% decarboxylation of all-trans-
retinoic acid in 4 hours. The biological significance of decarboxy-
lated retinoids was underscored in a 1964 study by Yagashita et al. 
(85) who found a decarboxylated metabolite of vitamin A from the 
small intestine that was biologically active. Numerous studies 
involving radioactive all-trans-retinoic acid have suggested decar-
boxylation, loss of hydrogen from position 11 or 12, and cleavage of 
the side chain into TCA cycle intermediates. Roberts et al. (86) 
proposed that retinoic acid underwent 3 main reactions in the body. 
The first led to metabolites with intact side chains and included 
formation of retinoyl 8-glucuronide. The second was decarboxylation 
of the terminal carboxyl leaving a 19-carbon retinoid. The third 
involved cleavage of the side chain of the decarboxylated compound 
into TCA cycle intermediates. The proposed alterations of retinoic 
·d b d h 1 · f 14c 3H · h i ac~ were ase on t e re at~ve amounts o or ~n t e ur ne or 
feces of animals dosed with combinations of all~trans-[6,7- 14c2 J, 
[15-14cJ, [14-14cJ, or [11,12-3H2Jretinoic acid. No metabolites 
corresponding to any of these 3 proposed types have been found. 
Hanni et al. (87) have isolated and identified 3 decarboxylated 
retinoids from rat urine. They reported that each of the 3 had the 
side chain shortened to position 12 and contained a 4-keto group. 
Two had the side chain in a furanone ring and the methyl at position 
1 was hydroxylated in one. The other metabolite had a hydroxylated 
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methyl group at carbon 1 and a mono-ene side chain ending in a carboxyl 
group. The three decarboxylated compounds were the only urinary 
retinoids isolated and accounted for 26% of urinary metabolites. 
Hanni et al. (88) also identified 3 fecal metabolites and accounted 
for 61% of the fecal retinoids. All had completely intact side chains. 
Hanni et al. combined the results of Olson's earlier studies (63, 
68-72) and their own in a proposed scheme on the pathway taken by 
retinoic acid through the body. The scheme, consistent with that of 
Roberts et al. (86), contains two hypothesis. 
The first states that retinoids without an intact side chain are 
removed by the kidney and excreted in the urine. 
The second states that metabolites with intact side chains pass 
through the bile and are excreted in the feces. 
Two of the cornerstone studies on which these hypotheses rest 
(63, 86), however, used chromatographic methods such as gas chroma-
tography (GC), thin layer chromatography (TLC) and·acid-base 
extractions that are not compatible with the labile nature of 
retinoids. 
Isolation of metabolites of retinoic acid has been hampered by 
the labile nature of the compound, poor separatory capabilities, and 
impurities in radiochemical precursors. 5,8-Epoxyretinoic acid has 
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been reported as a metabolite of retinoic acid and identified as a 
major impurity in stocks of 3H and 14c labelled all-trans-retinoic 
acid (89, 90). The identification of 13-cis retinoic acid as a 
metabolite of retinoic acid in the liver (91) remains questionable 
since the isolation procedure was shown to isomerize 60% of all-trans-
retinoic acid to the 13-cis isomer (91). The development of high 
performance liquid chromatography (HPLC) technology with bonded 
octadecylsilane columns has improved laboratory separations capabil-
ities. Halley and Nelson (92) isolated and identified, using Fourier 
transform nuclear magnetic resonance (FT-NMR), eleven photochemically 
produced cis-trans isomers of methyl retinoate by reverse-phase HPLC. 
It has recently been reported that using HPLC, Zile et al. (93) 
found retinoyl-S-glucuronide to be a minor bile metabolite, accounting 
for only 12% of bile retinoids. Earlier studies using gas chroma-
tography, thin layer chromatography and extractions placed the amount 
of retinoyl-8-glucuronide at 90% of bile retinoids (70). 
The higher figure found in the earlier studies was probably due 
to the incomplete separation of the glucuronide derivative from other 
metabolites. Routine HPLC analysis of bile retinoids revealed that 
at least one retinoid present was decarboxylated. This generated a 
conflict with earlier studies that concluded that only retinoids with 
intact side chains were in the bile. None of the earlier studies 
relied on HPLC as the chromatographic method. 
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The objective of the present study, therefore, was to investigate 
the bile retinoids using HPLC as the chromatographic method. 
The retinoic acid numbering system to be used in describing the 
retinoids is shown in Figure 1. 
2 
3 
4 
0 
II 
C-0-H 
15 
Figure 1. Numbering Syst~ for All-trans-Retinoic Acid 
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CHAPTER II 
SEPARATION AND CHARACTERIZATION OF METABOLITES OF 
ALL-TRANS- AND 13-CIS-RETINOIC ACID IN BILE 
Materials 
Chemicals 
All organic solvents used were low residue-distilled in glass 
HPLC grade solvents (Burdick & Jackson Laboratories, Inc., Muskegon, 
Mich.). All water was deionized and doubly distilled in glass. 
All-trans-[15-14c1- (27.3 mCi/mmol), all-trans-[11,12-3H2J- (3.1 
Ci/mmol), all-trans-[6,7-14c2J- (51 mCi/mmol), and nonradioactive 
all-trans-retinoic acid were gifts from Dr. W. E. Scott, Hoffmann 
La Roche, Inc. (Nutley, N.J.). All-trans-[10-3H]retinoic acid (2.8 
Ci/mmol) was supplied by New England Nuclear (Boston, Mass.) under 
contract to National Cancer Institute (NCI). 3 13-Cis-[11- H] (1.75 
Ci/mmol), and all-trans-[13,14-14c2]retinoic ·acid (51 mCi/mmol) were 
supplied by Midwest Research Institute also under contract to NCI. 
Nonradioactive 13-cis-retinoic acid was produced by reactions of all-
trans-retinoic acid with I 2 in the dark (75). Methyl retinoate was 
produced by reaction of all-trans-retinoic acid with diazomethane in 
the dark (78). Isomers of retinoic acid and methyl retinoate were 
produced by dissolving the sample in heptane, dimethylsulfoxide or 
methanol and placing it 6 inches from a Westinghouse FIST8/CW fluo-
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rescent lamp for 8 to 72 hours. All radioactive retinoids were 
purified at least twice by HPLC utilizing a 0.46 x 25 em Partisil 
PXS 10/25 ODS column (Whatman, Clifton, N.J.). The solvent used was 
65 methanol:35 0.01 M aqueous acetic acid. All·labelled retinoids 
were diluted with unlabelled isomerically identical retinoic acid to 
lower the specific activity to 90 ~Ci/mg and used within 1 hour of 
their final purification. All collections were in the dark under N2 
and were immediately extracted into carbon tetrachloride. 
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Nonradioactive 13-cis-retinoic acid was purified by HPLC utilizing 
a 0.94 x 50 em Whatman (Clifton, N.J.) M9-0DS column. The material 
was eluted at 1.5 ml/min with 95 methanol:S 0.01 M aqueous acetic acid. 
Nonradioactive all-trans-retinoic acid was used without additional 
purification since it eluted as a single peak from the HPLC. 
Animals 
Day old chicks, obtained from Dr. R. H. Thayer, Animal Science 
Department, Oklahoma State University (Stillwater, Okla.), were 
placed on a vitamin A deficient diet until they stopped gaining weight. 
At that time they were divided into 2 groups. One group was dosed 
orally with 20 ~g of all-trans-retinoic acid on Tuesdays and Fridays 
each week. The other group was dosed orally with 100 ~g 13-cis-
retinoic acid on Tuesdays and Fridays each week. The higher dosage 
required to keep chicks alive with 13-cis-retinoic acid is probably 
due to its lower biopotency relative to all-trans-retinoic acid. 
HPLC Systems 
Four HPLC systems, each equipped with a Valco (Houston, Tex.) 
model CV-6-UHPa-N60 sample injector, were used. System #1 was used 
to purify nonradioactive 13-cis-retinoic acid. It consisted of a 
Dupont Model 830 HPLC system connected to an M9-0DS2 (C-18) column 
(Whatman, Clifton, N.J.). Detection was at 254 nm. Material was 
eluted at 1.5 ml/minute with 95 methanol:5 0.01 M acetic acid. 
System #2 was used to separate bile retinoids. It consisted of an 
Isco model 314 pump connected to a Dupont Model 830 gradient maker. 
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The column employed for bile separations was an MCB (Cincinnati, Ohio) 
0.46 x 25 em C-8 column. Detection was at 254 nm. Additionally, a 
Beckman (Fullerton, Cal.) Model 25 scanning spectrometer was connected 
in series with the Dupont spectrophotometer. Material was eluted at 
0.5 ml/minute with 30 methanol:70 water. System #3 was also used 
for bile separations. It consisted of 2 Waters (Millford, Mass.) 
Model 6000A pumps controlled by a waters Model 660 gradient maker. 
The same column was used as in System #2. The material was eluted 
at 1 ml/minute with 35 methanol:65 0.01 M acetic acid. At 40 
minutes a one hour linear gradient to 100% methanol was initiated. 
Detection was at 254 nm with a Waters Model 440 spectrophotometer. 
System #4 was used for purification of radioactive retinoic acid 
samples. It consisted of a single Waters Model 6000A pump connected 
to a Whatman (Clifton, N.J.) 0.46 x 25 em Partisil 10/25 C-18 column. 
Detection was at 340 nm with a Waters Model 440 spectrophotometer. 
Material was eluted at 1 ml/minute with 65 methanol:35 0.01 M acetic 
acid. All columns were protected by Whatman (Clifton, N.J.) precolumns 
packed with CaPell ODS. 
Miscellaneous 
Glucuronide assays were performed with Sigma (St. Louis, Mo.) 
types G4882 and G3510 S-glucuronidase from beef liver (pH 4.85) and 
!· coli (pH 7.0) respectively. Ultraviolet spectral analyses were 
performed on a Hitachi (Mount View, Cal.) Model 100-80 scanning spec-
trophotometer. Radioactivity was determined on a Packard (Downers 
Grove, Ill.) Prias PL liquid scintillation counter. Packard Insta-
Gel was the scintillation fluid. Disintegrations per minute were 
calculated from counts per minute using computer programs developed 
by Bruce Halley and Kevin Ahern. Fractions off the HPLC column were 
collected with an Isco (Lincoln, Neb.) Model 328 fraction collector. 
Methods 
Chicks were injected intraperitoneally with labelled retinoids 
on a day when they would have been dosed orally with nonradioactive 
retinoids. Chicks were injected with 10 ~Ci (150 ~g) of the same 
retinoid they had been fed previously. Animals dosed with less than 
10 ~Ci of a labelled compound are noted separately. After injection 
of material the animals were provided with water. Six hours after 
injection, they were sacrificed by cervical dislocation and bile was 
removed with a syringe. It was immediately diluted with methanol 
(5 ml), filtered through a 0.5 ~m filter (Millipore type FH, Bedford, 
Mass.) eluted through a Waters (Millford, Mass.) C-18 Sep-Pak, 
evaporated to dryness under N2 and dissolved in 2 ml of methanol. 
Glucuronidase assays were performed with 5000-8000 Sigma units 
of glucuronidase dissolved in 1 ml of the appropriate buffer. 
15 
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Glucuronidase isolated from beef liver was diluted in a 0.075 M acetate 
buffer, pH 4.85. Glucuronidase from E. coli was dissolved in a 0.075 
M phosphate buffer, pH 7. The appropriate enzyme solution was added 
to a dried bile sample and incubated at 37°C for 2 hours. A control 
was run with identical treatment and the appropriate buffer but no 
enzyme. After 2 hours, the reaction mixture was injected directly 
into HPLC system #3, described in Materials. 
The bile metabolites were eluted at 1 ml/min with 35 methanol:65 
0.01 M acetic acid. At 40 minutes, a 1 hour gradient to 100% methanol 
was begun. The UV spectrum of metabolite #2 was obtained by evaporat-
ing the solvent under N2 and dissolving the residue in 2 ml of 
methanol. This was placed in a cuvette and scanned. Radioactive 
samples were diluted with 3-5 ml of Insta-Gel and allowed to stand 
for 2 hours before counting to eliminate chemiluminescence. 
Results 
PuriLy of Injected Retinoids 
Two prerequisites for the use of radioactive precursors in 
tracing metabolic pathways are the requirement that the precursor be 
radiochemically and isomerically pure and that the investigator check 
the purity of the starting materials. If either requirement is not 
met, the researcher is never sure if the radioactive metabolites 
isolated were formed from the precursor or are contaminants. The 
5,8 epoxy form of retinoic acid has been identified both as a metabo-
lite of all-trans-retinoic acid (90) and as a major contaminant in 
labelled retinoic acid stocks (89). 
Figure 2 illustrates the radiochemical purity of all-trans-
[10-3H]retinoic acid after purification by HPLC. The 13-cis isomer, 
eluting at 50 minutes is a typical contaminant of labelled all-
trans-retinoic acid before purification. After two purifications by 
HPLC, the 13-cis isomer accounted for less than 0.3% of the total 
radioactivity. 
Handling Controls 
17 
The chromatographic technique used for any metabolite purification 
should have as its number one priority - inertness toward sample. This 
has been a major problem with retinoids due to their labile nature. 
Previous experiments have clearly demonstrated the mild chromato-
graphic properties of HPLC. 
In any metabolic study involving labelled compounds it is impor-
tant that any artifacts of handling, extracting, or storing of the 
compounds not be identified as metabolites of the starting material. 
The extent of artifact production can be very difficult to determine. 
Before any bile sample was injected into the HPLC system it was 
diluted with methanol, filtered, and eluted from a C-18 Sep-Pak. If 
these measures were not taken, it was not possible to perform HPLC 
analyses due to column damage. Because it was not possible to leave 
out any of the handling procedures, the following experiment was 
designed to determine the effect of the handling procedures on all-
trans-retinoic acid. The chick was raised in the usual manner, but 
was injected with 0.25 ml of ethanol containing no retinoic acid six 
hours before sacrifice instead of with the usual radioactively 
labelled retinoic acid. At six hours bile was removed and diluted 
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Figure 2. HPLC Profile of Retinoic Acid Before (Dashed) and After 
(Solid) Purification 
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with 5 ml of methanol containing 1 x 106 DPM of all-trans-[l0-3H]-
retinoic acid. The mixture was filtered, eluted from a C-18 Sep-Pak 
and injected into HPLC system 3. The elution profile is shown in 
Figure 3. Only two regions received any significant radioactivity; 
the first, eluting between 5-10 mL, corresponded to the void volume 
of the system and might be an artifact of the injection process, 
the second, eluting between 97-100 mL, corresponded to free all-trans-
retinoic acid. That the material eluting between 97-100 minutes was 
free retinoic acid was shown when unlabelled all-trans-retinoic acid 
was injected into HPLC system 3 under the same conditions and eluted 
between 97-100 mL (Figure 4). The results presented here clearly 
indicate that no major alterations of retinoic acid occurred when 
bile was routinely handled for HPLC injection. Additionally, when 
bile was filtered and passed through a Sep-Pak three times, it did 
not alter the HPLC elution pattern when compared to once treated 
bile. 
All-trans Retinoic Acid Radiochemical Experiment 
A separation of bile retinoids by HPLC from chicks injected with 
either all-trans-[10-3H], [6,7-14c2 l, or [15-14c]retinoic acid is shown 
in Figures 5 and 6. The chicks dosed with all-trans-[6,7-14cJretinoic 
acid received only 2 ~Ci of material. Both the volumes of bile and 
the percentage of injected label found in the bile varied considerably. 
Bile volumes ranged from 0.3 to 2.0 ml. A maximum of 10% (15 ~g) of 
the injected label was recovered in the bile although typical recoveries 
ranged from 1-5% (1.5-7.5 ~g). 
The radioactive profile (Figure 5) revealed a wide range of 
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Figure 3. HPLC Profiles from System 3 of Ret~noic Acid After Handling Procedures 
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Figure 4. Elution Position of All-trans-Retinoic Acid from System 3 
N 
..... 
12 
" 
10 I 
0 ,.. 
8 )( 
:s 6 c. 
c 
(J 4 
• ...
2 
12 
ft 10 • C) 
,.. 
)( 8 
:E 
0.. 6 Q 
:J: 4 ft 
2 
Figure s. 
22 
10 20 30 40 50 60 70 80 90100 110 
MILLILITERS 
Comparison of HPLC Profiles from System 3 of Bile from 
Chicks Injected with All-trans-[15-14c]Retinoic Acid (~op) or All-trans-[10-3H]Retinoic Acid (Bottom) 
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Comparison of HPLC Profiles from System43 of Bile from 
Chicks Injected with All-trans-[6,7-1 Cz]Retinoic Acid 
(Top) .or All-trans-[l0-3H]Retinoic Acid (Bottom) 
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polarities of retinoic acid metabolites, ranging from unchanged retin-
oic acid at 98-100 minutes to the very polar water soluble metabolites 
eluting in the first 40 minutes. One of the most abundant metabolites 
in the pattern (henceforth referred to as metabolite 2) eluted between 
18-22 m1 and lacked radioactivity from carbon #15. All other 
3 . 14 
metabolites had both 10- H and 15- C. Chromatography of bile from 
chicks injected with all-trans-[6,7-14c]-retinoic acid confirmed that 
all peaks that contained l0-3H also contained 6,7-14c2 (Figure 6). 
The relative abundances of six bile retinoids are given in Table I. 
The HPLC elution pattern of bile from chicks injected with all-trans-
[6,7-14c2Jretinoic acid resembled the elution pattern of bile from 
chicks injected with all-trans-[15-~ 4Clretinoic acid for all peaks 
except metabolite 2 (Figure 7). Peak 2 was the only peak consistently 
lacking in [15-14c]. These data indicated the ring and side chain 
were intact for every major retinoid except metabolite 2. 
Each of the experiments described above utilized separate chicks 
injected with different radioactive labels, respectively, and were 
replicated over 30 times. A flaw inherent in such experiments is 
that the levels of metabolites produced in different animals could 
vary considerably depending on the amount of stress, physiological 
state or nutritional status of the organism. It could be possible 
14 that no 15- C was observed corresponding to metabolite 2 because 
those individual chicks injected with all-trans-[15-14c]retinoic acid 
produced either no or small amounts of metabolite 2. To provide 
conclusive evidence that metabolite 2 was decarboxylated, it was 
necessary to examine the metabolism of all-trans-[15-14c]retinoic 
acid and all-trans-[l0-3H]retinoic acid in a single animal. 
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Comparison of HPLC Profiles from System 3 of Bile from 
Chicks Injected ~ith All-trans-[ls-14c]Retinoic Acid (Top) 
or All-trans-[6;7-14c2]Retinoic Acid (Bottom) 
TABLE I 
RELATIVE ABUNDANCES OF SIX BILE RETINOIDS DERIVED 
FROM ALL-TRANS-[10-3H]RETINOIC ACID 
Metabolite No. 
1 
2 
3 
4 
5 
6 
Per Cent of Total Bile 
Radioactivity 
9.1 
15.9 
11.0 
9.1 
6.8 
2.5 
26 
Dual Label Experiment 
One chick was injected with 6 ~Ci of all-trans-[10-3H]retinoic 
acid and 4 ~Ci of all-trans-[15-14c]retinoic acid. The HPLC profile 
of bile metabolites from system #2 is shown in Figure 8. The HPLC 
column was eluted with 30 methanol:70 water. The metabolite from 
27 
peak 2 which eluted under these conditions between 19-20.5 ml, clearly 
contained 3H but no 14c, confirming that the metabolite from peak 2 
was decarboxylated. 
Characterization of Side Chain of Metabolite #2 
The experiments with all-trans-[6,7-14c2]retinoic acid, all-
trans-[10-3H]retinoic acid, and all-trans-[15-14c]retinoic acid 
revealed that the side chain was intact for all the bile metabolites 
of retinoic acid except the metabolite eluting in peak 2. Since 
the 10-3H position in the decarboxylated metabolite was present, it 
was obvious that the side chain was intact to at least carbon #10. 
An experiment was designed using all-trans-[13,14-14c2]retinoic acid 
to determine if radioactivity corresponding to at least one of these 
positions was present. A chick was injected with 10 ~Ci of all-
trans-[13,14-14c2Jretinoic acid and bile was prepared as described in 
methods. The HPLC profile (25% methanol, 75% water) from bile 
metabolites of retinoic acid is shown in Figure 9. The radioactivity 
peak observed between 42.5-45 ml corresponded to the decarboxylated 
metabolites. The radioactivity corresponding to the metabolite 
represented 26.3% of the total radioactivity in the bile. The average 
Figure 8. 
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HPLC Profile from System 2 of Bile from a Chick Injected 
with All-trans-[1S-14c]Retinoic Acid (Top) and All-
trans-[10-3H]Retinoic Acid (Bottom) 
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Figure 9. HPLC Profile from System 2 with 25 Methanol:{~ Water of Bile 
from Chicks Injected with All-trans- [13, 14- c2] Retinoic Acid 
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percentage of the total bile radioactivity corresponding to the 
metabolite eluting in peak 2 for chicks injected with different 
30 
radioactive labels is given in Table II. The values shown in the 
table are average values from six chicks for all labels but the 
[13,14-14c2] which was obtained from one chick. It was not possible 
to determine from these data whether or not carbon #14 was present, 
due to the fact that different animals could produce different amounts 
of metabolites. It was obvious, however, that at least carbon #13 
was present. 
Glucuronidase Experiments 
A significant finding in understanding the pathway that retinoic 
acid takes in its rapid transit through the body was the discovery by 
Zachman et al. (68) that most retinoic acid appeared in the bile 
within 24 hours of injection. Subsequent studies on bile revealed 
that retinoyl-S-glucuronide was a metabolite that accounted for up to 
90% of the bile retinoids. A more recent study has placed the figure 
closer to 12% (93) but, nevertheless, it was obvious from glucuronidase 
treatments that some metabolites of retinoic acid in the bile were 
linked to glucuronic acid residues. The only metabolite of retinoic 
acid previously identified using spectroscopic analysis in the bile was 
the identification by mass spectral analysis of retinoyl-S-glucuronide 
(93). All-trans-retinoic acid and all-trans-methyl retinoate have 
previously been reported present. All of these studies, however, 
utilized massive doses (3 mg) of retinoic acid. The formation of 
glucuronides under these conditions might represent a detoxification 
mechanism for handling the large amount of retinoids in the body. 
TABLE II 
AVERAGE PERCENTAGES OF TOTAL BILE RADIOACTIVITY CORRESPONDING 
TO METABOLITE 2 FOR DIFFERENT RADIOACTIVE LABELS 
Label 
6,7-14c2 
l0-3H 
13,14-14c2 
1s-14c 
Per Cent of Total Bile Radioactivity 
Corresponding to Metabolite 2 
15.9 
14.9 
26.3 
0.0 
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The following experiments were designed to locate and quantitate 
the glucuronic acid derivatives of all-trans-retinoic acid in the 
bile of chicks dosed with physiological doses of all-trans-retinoic 
acid. 
Beef Liver 6-Glucuronidase. Treatment of bile samples for 2 
hours at 37°C with glucuronidase isolated from beef liver (pH 4.85) 
produced only minimal changes in the chromatographic profile (Figure 
10) relative to a control (Figure 11). The peak between 98-100 
minutes was slightly increased by the treatment. This peak, which 
corresponded to free all-trans-retinoic acid, would be released from 
retinoyl-6-glucuronide by the enzyme treatment. All-trans-retinoic 
acid eluted in this region as shown in Figure 4. It was not apparent 
from the chromatographic profile which peak corresponded to the 
retinoyl-6-glucuronide derivative. 
Because these experiments produced inconclusive results about 
the existence of glucuronides among bile retinoids, experiments were 
conducted with glucuronidase isolated from E. coli (pH 7). The 
nonacidic conditions used in association with E. coli glucuronidase 
would be less conducive to artifact production. 
E. coli Glucuronidase Treatments. Figure 12 shows the HPLC pro-
file of radioactivity of bile retinoids isolated from chicks injected 
with all-trans-[10-3H]retinoic acid and then treated with E. coli 
6-glucuronidase as shown in Figure 13. The control sample of bile 
retinoids was incubated with the same Q.075 M phosphate buffer pH 
7.00 but without enzyme. Metabolites 1-4 showed no change in 
either peak positions or relative sizes on treatment with the enzyme, 
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consistent with the beef liver glucuronidase treatment. The E~ coli 
glucuronidase treatments indicated that 2 main regions of radioactivity 
were glucuronidase sensitive, having a reduced amount of radioactivity 
present relative to controls. Corresponding to the reduced amounts of 
metaboli~es between 77-80~ 83-85 and 92-95 m1 was the increase in the 
amounts of metabolites between 88-90 and 98-100 ml relative to con-
trols. Since the radioactive peak that eluted between 98-100 m1 
corresponded to free retinoic acid, it was apparent that a retinoyl 
ester of glucuronic acid was present in the bile. 
It was surprising that the glucuronic acid derivatives of retin-
oic acid and its metabolites would elute so late in the HPLC pattern. 
It was indicative that the glucuronides had polarities similar to 
all-trans-retinoic acid. The four bile retinoids eluting in the first 
50 ml of the HPLC pattern by contrast, were very polar, essentially 
water soluble. No one has ever reported any polar molecule attached 
to a retinoid in the bile except glucuronic acid. Clearly, the 
presence of a glucuronic acid moiety on a retinoid did not change the 
polarity of the retinoid very much, yet the first four retinoids were 
very polar. Obviously glucuronic acid was not polar enough to account 
for the very polar retinoids eluting in the first 50 ml. With the 
exception of the metabolite eluting in peak 2, all the polar compounds 
had intact side chains. It was not certain whether or not the ring 
was totally intact. It would appear from the evidence from the 
glucuronidase treatments that something previously totally undescribed 
had happened to alter these retinoids. With respect to the decarboxy-
lated retinoids, it is interesting to note that Luigi DeLuca (12), 
reviewing the work of Chen and Heller (60), postulated that a 
decarboxylated derivative of retinoic acid might be phosphorylated 
and function to transport mannose for incorporation into manno-
glycoproteins. This suggestion was based on the fact that when 
synthetic retinoyl phosphate was incubated with the cells, it did 
not function in uptake of mannose. When synthetic retinyl phosphate 
was used, it did function in transport of mannose. It was proposed 
that a terminal hydroxyl group might be present, since the compound 
chromatographed like retinol. For retinoic acid, this would require 
either reduction of the carboxyl group, which has never been demon-
strated in vivo, or decarboxylation to an alcohol. 
The polarity of.the decarboxylated compound is not unlike that 
of a phosphate, but there is not yet any evidence to indicate that a 
phosphate or any moiety is or is not present. 
38 
UV Absorbance 
Due to the different HPLC systems and conditions used in the 
separation of the decarboxylated retinoid, it was desirable to have 
a means to detect the decarboxylated retinoid in addition to radio-
activity. Numerous collections of the decarboxylated retinoid were 
pooled and the UV absorption spectrum was determined as shown in 
Figure 14. The apparent UV absorption maximum was 318 nm. It was 
possible that the apparent UV absorption maximum might not correspond 
to the metabolite. To help resolve this question, the following 
experiment was designed. The HPLC elution pattern at 318 nm for bile 
from a chick injected with all-trans-retinoic acid is shown in Figure 
15. Under these conditions (30 methanol:70 water) radioactivity 
profiles showed that the decarboxylated metabolite eluted between 
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Figure 15. HPLC Profile from System 2 of Bile from Chicks 
Supplemented with All-trans-Retinoic Acid 
27.5-30 ml and it can apparently be seen by the UV absorbance at 318 
nm between 27.5 and 30 ml also. Next, bile from chicks totally 
deficient in vitamin A and not supplemented with retinoic acid was 
injected into the HPLC. The UV elution pattern at 318 nm is shown 
in Figure 16. The decarboxylated retinoid which would elute between 
27.5-30 ml was not detected at 318 nm. The evidence that the metabo-
lite absorbed at 318 nm is not conclusive, but bile from chicks whose 
diet was supplemented with all-trans-retinoic acid contained a 
substance which absorbed at 318 nm and eluted in the same volume as 
the decarboxylated metabolite of retinoic acid while bile from chicks 
·deficient in vitamin A and unsupplemented with retinoic acid did not. 
Metabolism of 13-cis-Retinoic Acid 
41 
The metabolism of 13-cis-retinoic acid is important because of 
its use as a chemopreventive agent in some types of epithelial cancer. 
One study reported 13-cis-retinoic acid to be a metabolite of all-
trans-retinoic acid (91). The chromatographic system used, however, 
isomerized 60% of applied all-trans-retinoic acid to 13-cis-retinoic 
acid (91). A recent article by Frolik et al. (94) reported that a 
metabolite in the liver was common to hamsters dosed with either 13-
cis- or all-trans-retinoic acid. This hinted that the metabolism of 
13-cis-retinoic acid had features in common with metabolism of the 
all-trans-isomer. The question of whether or not 13-cis-retinoic acid 
is a metabolite of all-trans-retinoic acid has not been determined. 
If 13-cis-retinoic acid were an obligatory metabolite or "active form" 
of all-trans-retinoic acid through which all retinoic acid metabolites 
were formed, then one would expect that the metabolic profiles of bile 
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Figure 16. HPLC Profile from System 2 of Bile from Chicks 
No~ Supplemented with All-trans-Retinoic Acid 
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from chicks dosed with 13-cis-retinoic acid would be identical to that 
from all-trans-retinoic acid treated chicks. The following experiments 
were designed with 3 objectives; first to determine whether or not the 
decarboxylated retinoid present in all-trans treated chicks was 
present in 13-cis-retinoic acid treated chicks; second, to compare 
the metabolic profile in bile from 13-cis-retinoic acid treated chicks 
with the profile from all-trans-retinoic acid treated chicks; and 
third, to determine the status of free 13-cis-retinoic acid in bile 
from chicks treated with all-trans-retinoic acid. 
Chicks maintained on 13-cis-retinoic acid did not produce a radio-
active compound corresponding to the metabolite eluting in peak 2 
when injected with 13-cis-[ll-3H]retinoic acid. The top pattern in 
Figure 17 shows the metabolite eluting in peak 2 between 20.5-23 ml 
from a chick injected with all-trans-[13,14-14c2]retinoic acid, while 
the bottom is from a chick.injected with 13-cis-[ll-3H]retinoic acid. 
The absence of radioactivity corresponding to the metabolite in peak 2 
for 13-cis-retinoic acid bile did not necessarily mean nonproduction 
of the compound. Some experiments have suggested removal of a proton 
from the 11,12 position, although no such compound has been reported. 
It was apparent when bile profiles from 13-cis-[ll-3H]retinoic 
acid injected chicks were compared to all-trans-[13,14-14c2]retinoic 
acid injected chicks that there were very big differences in the way 
the 13-cis-isomer was metabolized, compared to the all-trans. The 
percentages of total biliary retinoids of each of the 13-cis- and 
all-trans- metabolites is given in Table III. The major discrepancies 
between the 2 profiles were in the areas of polar retinoids at the 
first part of the chromatogram. Only 14% of 13-cis- metabolites eluted 
Figure 17. 
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HPLC Profiles from System 2 of Bile from Chicks Injected 
with All-trans-[13,14- 14c2]Retinoic Acid (Top) or 
13-cis-[ll-3H]Retinoic Ac~d 
TABLE III 
COMPARISON OF ELUTION POSITIONS OF METABOLITES OF 
ALL-TRANS- AND 13-CIS-RETINOIC ACID 
ML Elution Range % of All-Trans- % of 13-Cis-Metabolites Metabolites 
2-5 15.4 3.5 
5.5-10 37.2 3.7 
10.5-15.5 16.4 4.8 
20-25 4.7 1.1 
31-35 1.7 16.0 
77-80 7.8 49.2 
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during the first 50 minutes of the HPLC profile versus 81% of the 
all-trans- metabolites. It should be remembered that the experiments 
with glucuronidase revealed that the glucuronides present in the bile 
eluted late in the HPLC pattern. Most of the 13-cis metabolites 
probably represent glucuronides of 13-cis-retinoic acid. It is not 
known why the 13-cis- isomer was not converted to the more polar 
derivatives or the significance of these derivatives in the metabolism 
of retinoic acid. The alternative explanation that the polar metabo-
lites were formed, but lost all tritium from C-11, however, seems 
unlikely. 
A recent report by Zile et al. (93) stated that 13-~-retinoic 
acid was indeed a metabolite of all-trans-retinoic acid in rats 
despite conflicting earlier reports. HPLC systems 2 and 3 used in 
separating metabolites in the bile were not capable of separating a 
mixture of all-trans- and 13-cis-retinoic acid due to the type of 
column used. To resolve 13-cis-retinoic acid from all-trans-retinoic 
acid, a modification of system 3 was made. The C-8 column was 
replaced by the M9-0DS-2 column from system 1. The elution conditions 
were changed as follows. The run solvent employed was 50 MeOH:50 0.01 
M acetic acid for 10 minutes, a 1 hour 20 minute gradient to 100% 
methanol, followed by 30 minute elution with 100% methanol. Under all 
of these conditions, 13~cis-retinoic acid eluted between 159-162 ml 
followed by the all-trans-retinoic acid between 169.5-172.5 ml. The 
HPLC elution pattern of radioactivity in bile from a chick injected 
with all-trans-[l0-3H]retinoic acid is shown in Figure 18. 
Very little free 13-cis between 159-162 m1 or all-trans-retinoic 
acid between 169.5-172.5 ml was observed in the HPLC patterns, con-
15 
12 
0 30 60 90 120 150 
MILLILITERS 
Figure 18. HPLC Profile from Modified System 3 of Bile from Chicks 
Injected with A1~7trans-Retinoic Acid 
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sistent with previous results. It was apparent, however, that a very 
small amount of radioactivity co-chromatographed with the 13-cis 
isomer between 159-162 ml, but because of the low amount of radio-
activity involved, it was not possible to determine if it was signif-
icant. 
Discussion 
The results presented here represent the first characterization 
of a decarboxylated retinoid in bile. The metabolite found in bile 
had the side chain intact to at least carbon #13, making it the 
decarboxylated retinoid with the longest side chain reported to date 
~ vivo. The decarboxylated metabolites found by Hanni et al. (87) 
in urine had the side chain cleaved back to position 12. 
All but one of the bile retinoids had the entire side chain 
intact. No fragments were detected. This partly confirmed previous 
studies that concluded that only retinoids with intact side chains 
48 
were present in the bile (63). It can only be speculated as to why 
previous investigations failed to discover the decarboxylated retinoid 
reported here. Other studies on the bile utilized massive quantities 
of retinoic acid (up to 3 mg vs. 150 ~g used here). Under conditions 
like that, the body might recognize retinoic acid as toxic and rapidly 
eliminate it via the bile in the rapidest way possible, and the 
normal metabolism might be obscured. Indeed, Lippel et al. (70) 
characterized 90% of the bile metabolites as retinoyl-8-glucuronide. 
By contrast, this study characterized only 7% of the metabolites as 
retinoyl-8-glucuronide. Earlier studies performed on the bile utilized 
chromatographic techniques such as thin layer chromatography, gas 
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chromatography and extraction that were not as compatible with the 
labile nature of retinoids nor capable of achieving the necessary 
separation of retinoids as HPLC. To trace metabolites by radioactive 
precursors it is necessary that the chromatography technique employed 
completely and reproducibly separate the metabolites formed, lest the 
radioactivity of one metabolite contaminate the sample of another. 
Another requirement in the use of radioactive precursors is that they 
be radiochemically and isomerically pure. If this condition is not 
met then some of the so-called "metabolites" formed represent con-
taminants or metabolites of contaminants. Using HPLC it was possible 
to purify all-trans-retinoic acid so that at most 0.3% of the material 
injected into the animal represented 13-cis-retinoic acid, a common 
contaminant of radiochemical stocks of retinoids. The importance of 
this is emphasized by the fact that many investigations have utilized 
unpurified radioactively labelled retinoids in metabolic studies, yet 
some of the retinoids we have used were less than 10% pure prior to 
purification. 
Glucuronidase treatments of the bile revealed that 11% of the 
bile retinoids are conjugated with glucuronic acid. Retinoyl-S-
glucuronide r·epresents 6.8% of the bile retinoids. This is lower 
than what had previously reported, but consistent with a recent 
report by Zile et al. (93). It was surprising to find very polar 
retinoids in bile that were not attached to glucuronic acid. Indeed, 
the glucuronides in bile eluted late in the HPLC pattern, corresponding 
to a polarity like that of retinoic acid. The explanation for the 
water solubility of the first three retinoids in the HPLC pattern of 
the bile is unknown. It is possible that a polar substituent such as 
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phosphate or sulfate is attached to the molecule. The first and the 
third metabolites in the pattern have intact side chains ending in a 
carboxyl group, presumably, since no evidence has ever been found that 
retinoic acid is reduced ~vivo. If a phosphate or sulfate is 
attached at the carboxyl end, forming a mixed anhydride, the resulting 
high energy bond might be unstable, yet HPLC patterns of these com~ 
pounds after incubation for 2 hours at 37°C indicated no decomposition. 
The material eluting in peak 2, however, lacked the terminal 
carboxyl group. Whether or not a new carboxyl group replaced the 
lost carboxyl group has not been determined. Luigi DeLuca (12), 
reviewing the work of Chen and Heller (60), proposed that a decarboxy-
lated retinoid with a hydroxyl group could be phosphorylated and bind 
mannose for transfer to mannoglycoprotein synthesis. If the decar-
boxylated retinoid ended in an alcohol instead of an acid, attachment 
of a phosphate or sulfate through an ester linkage would be more 
stable. 
The UV maximum of 318 nm corresponds to a loss of conjugation 
relative to the parent all-trans-retinoic acid with a UV maximum of 
350 nm. The decarboxylated C-19 aldehyde isolated by Rockley et al. 
(82) by contrast had a UV maximum of 280 nm. The C-19 aldehyde had 
conjugation interrupted at carbon #9 by hydroxylation resulting in two 
conjugated systems of 3 bonds each. The 3 decarboxylated retinoids 
found by Hanni et al. (87) in the urine had UV absorbance maxima at 
262 nm, 278 nm and 264 nm, with conjugation extending over 3, 3, and 
2 bonds, respectively. 
This indicates the retinoid reported here either has a more 
extended system of conjugation than previously reported decarboxy-
lation products of retinoic acid or that it is attached to a 
chromophore. 
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CHAPTER III 
SUMMARY 
In this study the metabolites of retinoic acid in chick bile were 
separated by reverse phase HPLC. Comparison of the radioactive 
profiles of bile from chicks injected with either all-trans-[6,7-14c2J-, 
[l0-3HJ or [15-14cJretinoic acid revealed that all metabolites but one 
had completely intact side chains. The decarboxylated metabolite 
was one of the most abundant retinoids and represented 15.9% of bile 
retinoids. It has a UV absorbance maximum of 318 nm, a blue shift 
relative to all-trans-retinoic acid. No radioactivity corresponding 
to it was produced in animals injected with 13-cis-[ll-3HJretinoic 
acid. 
Chicks maintained on 13-cis-retinoic acid have greatly reduced 
amounts of the very polar metabolites seen in the bile of chicks main-
tained on all-trans-retinoic acid. It is not clear whether or not 
13-cis-retinoic acid is a metabolite of all-trans-retinoic acid in 
the bile. 
Treatment of bile with 8-glucuronidase from !· coli and beef liver 
revealed 2 main regions of radioactivity contained glucuronic acid 
residues. Both have polarities similar to all-trans-retinoic acid. 
None of the water soluble metabolites eluting early in the pattern 
were altered by incubation~·with glucuronidase. 
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